Yanuki
Health / Pharmaceuticals
After more than four decades, a new prescription medicine has emerged to combat motion sickness. Vanda Pharmaceuticals has announced the U.S. commercial availability of NEREUS™ (tradipitant), offering a modern, targeted approach to prevent...
Business / Medical Pharmaceuticals
West Pharmaceutical Services has expanded its facility in Damastown, Dublin, to meet the growing demand for injectable therapies, including those for diabetes and obesity. This expansion aims to enhance the company's contract services and g...
Business / Corporate Expansion
West Pharmaceutical Services has expanded its facility in Damastown, Dublin, to meet the growing global demand for injectable therapies, particularly for diabetes and obesity treatments. This expansion aims to enhance contract services and...
Pharmaceuticals / Sleep Disorders
Eli Lilly and Company is set to acquire Centessa Pharmaceuticals for a potential total of $7.8 billion. This acquisition aims to advance treatments for sleep-wake disorders by leveraging Centessa's orexin receptor 2 (OX2R) agonists, which h...
Business / Biotech
San Diego-based biotech company Neomorph has begun its first clinical trial for NEO-811, a 'molecular glue' designed to make cancer cells self-destruct. This innovative approach has garnered significant attention and billions of dollars in...
News / Health
Winter weather can significantly disrupt travel, raising concerns for patients dependent on timely medication deliveries. UVA Health Pharmacy addresses these challenges by proactively preparing for storms to ensure patients receive their ne...
Health / Pharmacy
National Pharmacist Day (Jan. 12) highlights the crucial role pharmacists play in community health. Often the most accessible healthcare professionals, they provide a range of services from managing chronic conditions and administering vacc...
Business / Pharmaceuticals
Eli Lilly is expanding its U.S. manufacturing footprint with a significant $6 billion investment in a new facility in Huntsville, Alabama. This move aims to boost domestic medicine production and strengthen supply chain resilience.
Finance / Healthcare
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will participate in Citi’s 2025 Global Healthcare Conference on December 3, 2025. CFO Charlie Wagner and CSO David Altshuler will engage in a fireside chat at 9:00 a.m. ET. A live webcast w...
Healthcare / Pharma
The pharmaceutical industry is undergoing a significant shift towards patient-centric models, driven by rising expectations for convenience, transparency, and speed. Direct-to-Patient (DTP), Direct-to-Consumer (DTC), and Direct-to-Employer...
News / Partnerships
Monumental Sports & Entertainment (MSE) has announced Vanda Pharmaceuticals as a Founding Partner for Capital One Arena. This multi-year agreement includes naming rights for the Monumental Sports Network (MNMT) broadcast studio and extensiv...
Health / Infectious Diseases
Tonix Pharmaceuticals has licensed TNX-4800, a monoclonal antibody, from UMass Chan Medical School for the prevention of Lyme disease. This single-dose prophylactic aims to provide seasonal protection against the disease.
Finance / Stock Analysis
aTyr Pharma (ATYR -83.08%&ref=yanuki.com), a small-cap biotech firm, is generating buzz as it approaches the release of phase 3 clinical trial data for its leading drug candidate, efzofitimod. With its shares up 40% year-to-date, investors...
Finance / Stock Analysis
aTyr Pharma (NASDAQ:ATYR) has shown mixed performance recently, with its stock price experiencing fluctuations amid analyst rating changes and the outcome of a crucial Phase 3 trial for its lung disease treatment. This article provides a co...
Finance / Stock News
aTyr Pharma (ATYR) recently announced topline results from its Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis. While the study showed some positive secondary outcomes, it failed to meet its primary endpoint, leading to a mi...
Health / Mental Health
AbbVie (NYSE: ABBV) has acquired Gilgamesh Pharmaceuticals' Bretisilocin, a novel investigational therapy for major depressive disorder (MDD), for up to $1.2 billion. This acquisition significantly expands AbbVie's psychiatry pipeline and u...
Money / Markets
Vertex Pharmaceuticals (NASDAQ:VRTX) is preparing to announce its latest earnings. Investors are keen to understand how the stock will react, considering its historical performance and recent financial results.
Finance / Earnings
Vertex Pharmaceuticals (VRTX) reported a 12% increase in total revenue for the second quarter of 2025, reaching $2.96 billion. This growth was fueled by strong performance in cystic fibrosis (CF) therapies and the successful launches of new...
Markets / Earnings
This week, investors are keenly awaiting earnings reports from major companies across various sectors, including technology, consumer goods, and pharmaceuticals. Key economic data releases and Federal Reserve commentary will also influence...
Finance / Stocks
Despite strong track records and substantial market caps, Merck, Novo Nordisk, and Pfizer are considered by some analysts to be surprisingly undervalued. This article explores the reasons behind this perception and the potential opportuniti...
